The Effects of Very Early Use of Rosuvastatin in Preventing Recurrence of Ischemic Stroke

PHASE3TerminatedINTERVENTIONAL
Enrollment

318

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Stroke
Interventions
DRUG

Rosuvastatin

Rosuvastatin 20mg tablet, once daily, for 14 days

OTHER

Placebo tablet

Placebo tablet, once daily, for 14 days

Trial Locations (27)

Unknown

Department of Neurology, Hallym University Sacred Heart Hospital, Anyang

Department of Neurology Colleage of Medicine Dong-A University, Busan

Department of Neurology Pusan National University Hospital, Busan

Department of Neurology, College of Medicine Inje University, Paik Hospital, Busan

Department of Neurology, Fatima hospital, Changwon

Department of Neurology, Samsung Changwon hospital, Changwon

Department of Neurology, Dongsan Medical Center, Keimyung University School of Medicine, Daegu

Department of Neurology, Yeungnam University School of Medicine, Daegu

Department of Neurology Konyang University Hospital, Daejeon

Department of Neurology, Chonnam National University Hospital, Gwangju

Department of Neurology, Chosun University Hospital, Gwangju

Department of Neurology, Inha University Hospital, Incheon

Department of Neurology, National health insurance corporation ilsan Hospital, Koyang-shi

Department of Neurology Gangnam Severance Hospital, Seoul

Department of Neurology Kyung Hee University East-West Neo Medical Center, Seoul

Department of Neurology Seoul National University Hospital, Seoul

Department of Neurology St. Mary's Hospital, Catholic University, Seoul

Department of Neurology, Ewha Womans University Hospital, Seoul

Department of Neurology, Hallym University Medical Center, Seoul

Department of Neurology, Korean University Guro hospital, Seoul

Department of Neurology, Kyung Hee University, College of Medicine, Seoul

Department of Neurology, National Medical Center, Seoul

Department of Neurology, Samsung Medical Center, Seoul

Department of Neurology, University of Ulsan,Asan Medical Center, Seoul

Department of Neurology,Sanggye Paik Hospital, Inje University College of Medicine, Seoul

Department of Neurology, Wonju Christian Hospital, Wŏnju

120-752

Department of Neurology, Severance Hospital, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Severance Hospital

OTHER